Exane Derivatives’s American Assets Trust AAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15
Closed -$568 761
2022
Q1
$568 Hold
15
﹤0.01% 847
2021
Q4
$563 Hold
15
﹤0.01% 759
2021
Q3
$561 Hold
15
﹤0.01% 929
2021
Q2
$554 Buy
+15
New +$534 ﹤0.01% 933
2021
Q1
Sell
-15
Closed -$433 881
2020
Q4
$433 Hold
15
﹤0.01% 751
2020
Q3
$361 Hold
15
﹤0.01% 699
2020
Q2
$418 Hold
15
﹤0.01% 623
2020
Q1
$375 Sell
15
-4,694
-100% -$190K ﹤0.01% 626
2019
Q4
$218K Buy
4,709
+4,491
+2,060% +$210K 0.04% 243
2019
Q3
$10.2K Sell
218
-4,220
-95% -$198K ﹤0.01% 432
2019
Q2
$209K Buy
+4,438
New +$204K 0.04% 258

Other funds holding AAT

Exane Derivatives's AAT Position: Q2 2022 in Review

Exane Derivatives sold out of American Assets Trust (AAT) in Q2 2022, closing a stake of 15 shares — an estimated $568 sold.

Exane Derivatives first reported a position in AAT in Q2 2019 and held it in 11 quarters. The position peaked at $218K in Q4 2019. 200 funds tracked by Wall St. Rank hold AAT as of Q2 2022.

  • Exane Derivatives reported no remaining American Assets Trust position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 15 American Assets Trust shares in Q2 2022, an estimated $568.
  • Exane Derivatives first reported a position in American Assets Trust in Q2 2019 and held it in 11 quarters.
  • Exane Derivatives's American Assets Trust position peaked at $218K in Q4 2019.
  • 200 funds tracked by Wall St. Rank held American Assets Trust as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.